Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble guanylate cyclase activators

Soluble guanylate cyclase activators

US Patent 9783552 · Granted Oct 10, 2017

Estimated economic value: $124,275,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Property modulation with chemical transformations2025
Synthetic extracellular vesicles for novel therapies2024
Chromane amidine monobactam compounds for the treatment of bacterial infections2024
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2024
Heteroaryl compounds useful as MK2 inhibitors2023
Site-specific antibody-drug conjugates by ADP-ribosyl cyclases2023
Functionalized poly-ADP-ribose polymers for drug delivery2022
Intravenous injection for enhancing immune function2022
Methods of curing HBV infection and providing complete protection against HBV in2021
Heteroaryl compounds useful as MK2 inhibitors2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Factor XIIa inhibitors2021